Ziqiang Ding

Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy

Fengzhen Mo, Siliang Duan, Xiaobing Jiang et al. · Signal Transduction and Targeted Therapy · 2021 · 72 citations · Full text

A new PD-1-specific nanobody enhances the antitumor activity of T-cells in synergy with dendritic cell vaccine

Wei Shi, Xiaomei Yang, Shenxia Xie et al. · Cancer Letters · 2021 · 39 citations

Nanomedicine, Cancer Immunosurveillance, Antitumor Activity +10

Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression

Ziqiang Ding, Shuyang Sun, Xuan Wang et al. · Journal of Hematology & Oncology · 2023 · 23 citations · Full text

Vascular barrier-enhancing effect of an endogenous?-adrenergic agonist

Ziqiang Ding, Meizhen Jiang, Shaohua Li et al. · Inflammation · 1995 · 22 citations

Adrenal Gland, Medicine, Physiology +6

A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumor

Shuyang Sun, Ziqiang Ding, Li Gao et al. · Theranostics · 2023 · 20 citations · Full text